ATRA
Atara Biotherapeutics Inc
9.80$
+3.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.38 | -154.43 | -83.37 | -36.31 | -52.23 | -73.25 | -102.58 | -114.81 | -61.09 | -58.86 | -66.29 | -45.55 | -9.18 | -4.01 | |
| – | 0.10 | 0.03 | 0.05 | 0.33 | 0.80 | 2.13 | 3.44 | 2.82 | 2.49 | 1.39 | 1.14 | 0.67 | 0.19 | |
| 1.19 | 44.34 | 50.65 | 10.02 | 14.60 | 19.34 | 19.30 | 25.19 | 17.35 | 14.38 | 13.20 | 10.71 | 3.61 | 0.77 | |
| – | 3.83 | 54.41 | 10.11 | 14.60 | 19.34 | 19.42 | 25.69 | 17.40 | 15.37 | 0.88 | – | – | – | |
| – | 28.32 | -0.02 | 6.05 | -0.63 | 6.03 | 8.56 | -2.02 | 21.52 | 14.03 | -15.07 | 3.62 | -4.13 | -8.24 | |
| 0.04 | 0.08 | 0.23 | 0.28 | 2.63 | 16.94 | 20.50 | 2.79 | 1.53 | 2.82 | 1.03 | 0.29 | 0.03 | 0.00 | |
| -0.04 | -0.08 | -417.99 | -215.11 | 72.86 | 82.63 | -112.01 | 29.46 | -40.80 | 5.94 | 49.75 | 29.24 | 1.15 | 1.43 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | 3.26 | 0.51 | 0.33 | 0.15 | – | – | – | |
| – | – | 350.66 | -4.54 | -0.08 | -0.30 | -4.28 | -3.26 | -0.51 | -0.33 | -0.15 | -0.02 | – | – | |
| – | – | 1.69 | -0.52 | -0.46 | 8.29 | -0.30 | -0.24 | -0.13 | -0.07 | 7.37 | -0.22 | -0.12 | -0.02 | |
| 20.62 | 1,381.64 | 352.35 | 253.32 | 0.44 | 16.78 | 204.02 | 91.99 | 144.50 | 27.74 | 13.01 | 0.47 | 7.92 | 1.27 | |
| 17.21 | 1,227.14 | -149.01 | 1.81 | 21.08 | 26.17 | -10.57 | 6.64 | 42.61 | -25.17 | -3.53 | -15.84 | -0.11 | -1.31 | |
| -3.41 | -154.51 | -83.60 | -36.59 | -54.86 | -90.19 | -123.08 | -117.60 | -62.61 | -61.68 | -67.32 | -45.84 | -9.21 | -4.01 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.